Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

V Gondi,S Pugh,M.P Mehta,J.S Wefel,W.A Tome,A Sun,G.M Videtic,B.H Lok,H.A Yoon,J.H Heinzerling,A.S Denittis,R.C Mcgarry,K Devisetty,V Kundapur,A.J Wu,R Paulus,L.A Kachnic

doi:10.1016/j.ijrobp.2023.08.028

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

V Gondi, S Pugh + Show 15 more

https://doi.org/10.1016/j.ijrobp.2023.08.028

Copy DOI

Export

Save

Cite

Journal: International Journal of Radiation OncologyBiologyPhysics	Publication Date: Oct 12, 2023
Citations: 10

Affiliation: Northwestern Medicine, NRG Oncology, Florida International University, The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, University of Toronto, Cleveland Clinic, Southeast Radiation Oncology Group, Levine Cancer Institute, Wayne State University, Memorial Sloan Kettering Cancer Center

#Prophylactic Cranial Irradiation #Hippocampal Avoidance #Small Cell Lung Cancer #Cranial Irradiation #Small Cell #Primary Endpoint #Lung Cancer

Abstract
Full-Text
Similar Papers

Abstract

Listen

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: International Journal of Radiation OncologyBiologyPhysics

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Primary Endpoint Results of NRG CC003: Phase IIR/III Trial of Prophylactic Cranial Irradiation (PCI) with or without Hippocampal Avoidance (HA) for Small Cell Lung Cancer (SCLC)